See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: Jan. 4, 2007

Human Papilloma Virus (HPV) Asthma (Pediatric) or Asthma Athlete's Foot (Tinea Pedis)

(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:

Human Papilloma Virus (HPV)

This study will test an investigational use of a drug to treat women infected with human papillomavirus (HPV). Women 18-40 who have a cervical sample that is HPV positive, have not received an active HPV vaccine before the study, or haven't used an experimental drug within 60 days of the study may qualify. Participants may also not have tested positive for HIV.

The research site is in New York, NY.

More information

Please see


Asthma (Pediatric) or Asthma

This research study is for asthmatic children ages 4-11. Children with a history of asthma for at least three months who are in good general health may be eligible. The study consists of eight visits over approximately 14 weeks, and participants may be reimbursed for time and travel.

The research site is in St. Louis, Mo.

More information

Please see


Athlete's Foot (Tinea Pedis)

Volunteers 12 or older with athlete's foot may be eligible for this study, which will involve three clinic visits over 42 days, administration of an investigational drug or placebo, foot examination, and lab work. Compensation is available for time and travel (up to $105 for study completion).

The research site is in Mount Pleasant, SC.

More information

Please see


Copyright 2007 Thomson CenterWatch. All rights reserved.

Consumer News


HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.